An activating mutation of interferon regulatory factor 4 (IRF4) in adult T-cell leukemia
Mathew Cherian(The Ohio State University Wexner Medical Center), Daniel A. Rauch(Washington University in St. Louis)
Cited by 27
Related Papers
Bioluminescence imaging of myeloperoxidase activity in vivo
|Nature Medicine|2009|340
Rapid progression of adult T-cell leukemia/lymphoma as tumor-infiltrating Tregs after PD-1 blockade
|Blood|2019|106
Matched cohort study of germline BRCA mutation carriers with triple negative breast cancer in brightness
|npj Breast Cancer|2021|37
Activity of Estrogen Receptor β Agonists in Therapy-Resistant Estrogen Receptor-Positive Breast Cancer
|Frontiers in Oncology|2022|20
Interferon regulatory factor 4 as a therapeutic target in adult T-cell leukemia lymphoma
|Retrovirology|2020|16